Journal Article
. 2019 Dec;11().
doi: 10.2147/CMAR.S215000.

A Nomogram To Predict The Overall Survival Of Breast Cancer Patients And Guide The Postoperative Adjuvant Chemotherapy In China

Xin Wang 1 Ziwei Feng 1 Yubei Huang 1 Haixin Li 1 Ping Cui 1 Dezheng Wang 2 Hongji Dai 1 Fangfang Song 1 Hong Zheng 1 Peishan Wang 1 Xuchen Cao 3 Lin Gu 4 Jin Zhang 5 Fengju Song 1 Kexin Chen 1 
Affiliations
  • PMID: 31819635
  •     42 References
  •     2 citations

Abstract

Purpose: We aim to construct a nomogram to predict breast cancer survival and guide postoperative adjuvant chemotherapy in China.

Patients And Methods: A total of 5,504 breast cancer patients from the Tianjin Breast Cancer Cases Cohort were included. Multivariable Cox regression was used to investigate the factors associated with overall survival (OS) and a nomogram was constructed based on these prognostic factors. The nomogram was internal and external validated and the performance was evaluated by area under the curve (AUC) and calibration curve. The partial score was also constructed and stratified them into low, moderate and high-risk subgroups for death according to the tripartite grouping method. Multivariate Cox regression analysis and the propensity score matching method were respectively used to test the association between adjuvant chemotherapy and OS in different risk subgroups.

Results: Age, diameter, histological differentiation, lymph node metastasis, estrogen, and progesterone receptor were incorporated into the nomogram and validation results showed this nomogram was well-calibrated to predict the 3-year [AUC =74.1%; 95% confidence interval (CI): 70.1-78.0%] and 5-year overall survival [AUC =72.3%; 95% CI: 69.6-75.1%]. Adjuvant chemotherapy was negatively associated with death in high risk subgroup [Hazard Ratio (HR) = 0.54; 95% CI: 0.37-0.77; P<0.001]. However, no significant association were found in groups with low (HR=1.47; 95% CI: 0.52-4.19; P=0.47) and moderate risk (HR=0.78; 95% CI: 0.42-1.48; P=0.45). The 1:1 PSM generated 822 pairs of well-matched patients and Kaplan-Meier showed the high-risk patients could benefit from chemotherapy, whereas low risk and moderate risk subjects did not appear to benefit from chemotherapy.

Conclusion: Not all of the breast cancer patients benefit equally from chemotherapy. The nomogram could be used to evaluate the overall survival of breast cancer patients and predict the magnitude of benefit and guide adjuvant chemotherapy for breast cancer patients after surgery.

Keywords: adjuvant chemotherapy; breast cancer; cohort study; prognostic prediction.

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.
C L Carter, C Allen, D E Henson.
Cancer, 1989 Jan 01; 63(1). PMID: 2910416
Highly Cited.
Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients.
Nirmala Bhoo-Pathy, Cheng-Har Yip, +7 authors, Helena M Verkooijen.
Eur J Cancer, 2012 Mar 01; 48(7). PMID: 22366561
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, +4 authors, J J Mulvihill.
J Natl Cancer Inst, 1989 Dec 20; 81(24). PMID: 2593165
Highly Cited.
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
Bernard Fisher, Jong-Hyeon Jeong, +5 authors, National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
Lancet, 2004 Sep 08; 364(9437). PMID: 15351193
Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.
José Luiz B Bevilacqua, Michael W Kattan, +3 authors, Kimberly J Van Zee.
J Clin Oncol, 2007 Aug 01; 25(24). PMID: 17664461
The relationship between prognostic and predictive factors in the management of breast cancer.
I C Henderson, A J Patek.
Breast Cancer Res Treat, 1999 Mar 05; 52(1-3). PMID: 10066087
Review.
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R Peto, +15 authors, K Pritchard.
Lancet, 2011 Dec 14; 379(9814). PMID: 22152853    Free PMC article.
Highly Cited.
Population-based validation of the prognostic model ADJUVANT! for early breast cancer.
Ivo A Olivotto, Chris D Bajdik, +6 authors, Karen A Gelmon.
J Clin Oncol, 2005 Apr 20; 23(12). PMID: 15837986
Highly Cited.
Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, +13 authors, Stephen H Friend.
Nature, 2002 Feb 02; 415(6871). PMID: 11823860
Highly Cited.
Predictive model for survival in patients with advanced cancer.
Edward Chow, Mohamed Abdolell, +4 authors, Ian Tannock.
J Clin Oncol, 2008 Nov 20; 26(36). PMID: 19018082
The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.
T Korhonen, T Kuukasjärvi, +4 authors, L Pylkkänen.
Breast, 2013 Jul 19; 22(6). PMID: 23863867
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Evaluating Discrimination of Risk Prediction Models: The C Statistic.
Michael J Pencina, Ralph B D'Agostino.
JAMA, 2015 Sep 09; 314(10). PMID: 26348755
Highly Cited.
c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer.
O Stål, S Sullivan, +4 authors, B Nordenskjöld.
Eur J Cancer, 1995 Dec 01; 31A(13-14). PMID: 8652240
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet, 2005 May 17; 365(9472). PMID: 15894097
Highly Cited.
Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
Stella Mook, Marjanka K Schmidt, +6 authors, Peter M Ravdin.
Lancet Oncol, 2009 Oct 06; 10(11). PMID: 19801202
Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?
Philippe L Bedard, Fatima Cardoso.
Nat Rev Clin Oncol, 2011 Mar 03; 8(5). PMID: 21364525
Review.
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.
P M Ravdin, L A Siminoff, +4 authors, H L Parker.
J Clin Oncol, 2001 Feb 22; 19(4). PMID: 11181660
Highly Cited.
Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
Jennifer J Griggs, Sarah T Hawley, +8 authors, Steven J Katz.
J Clin Oncol, 2012 Aug 08; 30(25). PMID: 22869890    Free PMC article.
Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population.
Lea Rossi, Denise Stevens, +5 authors, Roman Rouzier.
PLoS One, 2015 Jul 28; 10(7). PMID: 26214853    Free PMC article.
Adjuvant chemotherapy in older women with early-stage breast cancer.
Hyman B Muss, Donald A Berry, +23 authors, CALGB Investigators.
N Engl J Med, 2009 May 15; 360(20). PMID: 19439741    Free PMC article.
Highly Cited.
Predictive model for survival in patients having repeat radiation treatment for painful bone metastases.
Edward Chow, Keyue Ding, +15 authors, Ralph M Meyer.
Radiother Oncol, 2015 Oct 31; 118(3). PMID: 26515411
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.
Jaclyn L F Bosco, Rebecca A Silliman, +7 authors, Timothy L Lash.
J Clin Epidemiol, 2009 May 22; 63(1). PMID: 19457638    Free PMC article.
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study.
Nienke A de Glas, Willemien van de Water, +9 authors, Gerrit-Jan Liefers.
Lancet Oncol, 2014 May 20; 15(7). PMID: 24836274
Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, +6 authors, Jie He.
CA Cancer J Clin, 2016 Jan 26; 66(2). PMID: 26808342
Highly Cited.
Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer.
Yan Zhang, Hua Gao, +2 authors, Jihui Jia.
World J Surg Oncol, 2013 Nov 02; 11. PMID: 24175997    Free PMC article.
C-erbB-2 overexpression and survival in early onset breast cancer.
M Agrup, O Stål, K Olsen, S Wingren.
Breast Cancer Res Treat, 2000 Nov 18; 63(1). PMID: 11079156
PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
Gordon C Wishart, Elizabeth M Azzato, +5 authors, Paul D P Pharoah.
Breast Cancer Res, 2010 Jan 08; 12(1). PMID: 20053270    Free PMC article.
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.
D Craig Allred, Robert W Carlson, +11 authors, Antonio C Wolff.
J Natl Compr Canc Netw, 2009 Dec 03; 7 Suppl 6. PMID: 19755043
Review.
The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.
Qingkun Song, Rong Huang, +10 authors, Youlin Qiao.
PLoS One, 2013 Aug 27; 8(8). PMID: 23977244    Free PMC article.
The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies.
Peter C Austin.
Med Decis Making, 2009 Aug 18; 29(6). PMID: 19684288
Highly Cited.
Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.
Kuo Yao-Lung, Chen Dar-Ren, Chang Tsai-Wang.
BMC Med Inform Decis Mak, 2012 Sep 19; 12. PMID: 22985190    Free PMC article.
Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results.
M Alan Brookhart, Sebastian Schneeweiss.
Int J Biostat, 2007 Jan 01; 3(1). PMID: 19655038    Free PMC article.
Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, +3 authors, Ahmedin Jemal.
CA Cancer J Clin, 2015 Feb 06; 65(2). PMID: 25651787
Highly Cited.
The adjuvant treatment of HER2-positive breast cancer.
Danijela Jelovac, Antonio C Wolff.
Curr Treat Options Oncol, 2012 Mar 14; 13(2). PMID: 22410709
Review.
Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration.
F Bray, J Ferlay, +9 authors, D Forman.
Int J Cancer, 2015 Jul 03; 137(9). PMID: 26135522
Highly Cited.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, +3 authors, Ahmedin Jemal.
CA Cancer J Clin, 2018 Sep 13; 68(6). PMID: 30207593
Highly Cited.
Effect of screening and adjuvant therapy on mortality from breast cancer.
Donald A Berry, Kathleen A Cronin, +8 authors, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators.
N Engl J Med, 2005 Oct 28; 353(17). PMID: 16251534
Highly Cited.
Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model.
Valerie Francescutti, Forough Farrokhyar, +4 authors, Kamyar Kahnamoui.
Cancer Chemother Pharmacol, 2010 Dec 03; 68(3). PMID: 21125276
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, +29 authors, Antonio C Wolff.
J Clin Oncol, 2010 Apr 21; 28(16). PMID: 20404251    Free PMC article.
Highly Cited. Systematic Review.
International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
A Morabia, M C Costanza.
Am J Epidemiol, 1998 Dec 29; 148(12). PMID: 9867266
Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram.
Yan-Bo Xu, Hong Liu, +3 authors, Dong Xu.
Cancer Med, 2020 Apr 22; 9(12). PMID: 32314546    Free PMC article.
Nomogram for predicting occurrence and prognosis of liver metastasis in colorectal cancer: a population-based study.
Mingshuang Tang, Hongmei Wang, +3 authors, Lihua Wang.
Int J Colorectal Dis, 2020 Sep 24; 36(2). PMID: 32965529